The effect of emotional self- disclosure on disease activity, health status and sexual function in women with rheumatoid arthritis

Not Applicable

Recruiting

• Conditions: Rheumatoid arthritis.; Rheumatoid arthritis with rheumatoid factor

• Registration Number: IRCT20110629006917N6
• Lead Sponsor: Iran University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 29 August 2022

Recruitment & Eligibility

• Status: Recruiting
• Sex: Female
• Target Recruitment: 72

Inclusion Criteria

Age 18-45 years
At least 6 months have passed since the diagnosis of the disease
Able to read and write in Farsi
Living with a spouse at the time of the study
Having sexual activity at least once in the last 4 weeks
Monogamous husband
Living in Tehran

Exclusion Criteria

Suffering from another chronic disease other than Rheumatoid arthritis in research units
Current pregnancy or breastfeeding and less than 6 months have passed since the last delivery
According to the patient, the occurrence of a stressful incident 3 months before the intervention
Suffering from major medical diseases affecting sexual relations (Diabetes, history of psychiatric disorders such as severe Depression, Psychosis, Bipolar disorder, substance abuse) according to the patient' statement and the contents of his file
Taking drugs affecting sexual performance
Sexual disorders under treatment in women or husbands (desire phase disorder, arousal phase disorder, orgasm disorder, sexual pain disorders)

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Disease activity. Timepoint: In each of the two test and control groups before the start of the study and 8 weeks after the intervention. Method of measurement: In both groups, it will be measured by a rheumatology specialist using the 28-DAS tool.;Health status. Timepoint: The measurement of this variable will be done before the start of the study, immediately and 8 weeks after the end of the intervention. Method of measurement: Completing the health status questionnaire (AIMS2-SF) by the participants.;Sexual function. Timepoint: The measurement of this variable in all 6 areas will be done before the start of the study, immediately and 8 weeks after the end of the intervention. Method of measurement: Completion of the Female Sexual Function Index (FSFI) questionnaire by the participants.